Friday, 9 October 2026European Markets

BLEECKER, HOME INVEST BE., Another 2 Companies Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(VIANEWS) - BLEECKER (BLEE.PA) is among this list of stock assets with the highest dividend rate and return on equity on the Real Estate sector.

Financial Asset Price Forward Dividend Yield Return on Equity
BLEECKER (BLEE.PA) €200.00 18.23% 26.04%
HOME INVEST BE. (HOMI.BR) €19.84 8.34% 14.88%
INCLUSIO SA/NV (INCLU.BR) €15.70 3.19% 12.56%
SHURGARD (SHUR.BR) €43.95 2.59% 27.09%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. BLEECKER (BLEE.PA)

18.23% Forward Dividend Yield and 26.04% Return On Equity

Bleecker Société Anonyme, a property company, operates in the real estate sector in France. The company develops and manages industrial premises, offices, and logistics platforms. As of August 31, 2010, it had 26 properties or property complexes covering a surface area of 208,228 square meters. The company is based in Paris, France.

Earnings Per Share

As for profitability, BLEECKER has a trailing twelve months EPS of €28.31.

PE Ratio

BLEECKER has a trailing twelve months price to earnings ratio of 7.06. Meaning, the purchaser of the share is investing €7.06 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.04%.

Volatility

BLEECKER's last week, last month's, and last quarter's current intraday variation average was a negative 1.00%, a negative 1.49%, and a positive 4.77%.

BLEECKER's highest amplitude of average volatility was 1.00% (last week), 3.93% (last month), and 4.77% (last quarter).

More news about BLEECKER.

2. HOME INVEST BE. (HOMI.BR)

8.34% Forward Dividend Yield and 14.88% Return On Equity

Home Invest Belgium S.A. operates as a real estate investment company in Belgium. It primarily invests in residential properties. As of December 31, 2008, the company's real estate portfolio consisted of 992 rental units with a total rentable space of approximately 111,091 square meters. The company was formerly known as Home Invest and changed its name to Home Invest Belgium S.A. in May 1999. Home Invest Belgium S.A. was founded in 1980 and is based in Brussels, Belgium.

Earnings Per Share

As for profitability, HOME INVEST BE. has a trailing twelve months EPS of €5.74.

PE Ratio

HOME INVEST BE. has a trailing twelve months price to earnings ratio of 3.45. Meaning, the purchaser of the share is investing €3.45 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.88%.

More news about HOME INVEST BE..

3. INCLUSIO SA/NV (INCLU.BR)

3.19% Forward Dividend Yield and 12.56% Return On Equity

Inclusio SA operates as a real estate company in Belgium. It focuses on affordable rental housing, housing for disabled, and social infrastructures. The company was incorporated in 2011 and is based in Brussels, Belgium.

Earnings Per Share

As for profitability, INCLUSIO SA/NV has a trailing twelve months EPS of €0.01.

PE Ratio

INCLUSIO SA/NV has a trailing twelve months price to earnings ratio of 2242.86. Meaning, the purchaser of the share is investing €2242.86 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.56%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 11M for the twelve trailing months.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 23, 2022, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 3.19%.

More news about INCLUSIO SA/NV.

4. SHURGARD (SHUR.BR)

2.59% Forward Dividend Yield and 27.09% Return On Equity

Shurgard Self Storage S.A., together with its subsidiaries, engages in the acquisition, development, and operation of self-storage facilities for business and personal use. The company also offers various ancillary services at its self-storage facilities consisting of sale of storage products and provision of protection through an independent insurance company for customers' stored goods. As of December 31, 2021, it owned and operated 254 self-storage facilities that covered an approximately 1.3 million net rentable square meters under the Shurgard brand name in the Netherlands, France, Sweden, the United Kingdom, Belgium, Germany, and Denmark; and operate one facility in France which is owned by a third party. The company serves approximately 174,000 customers. Shurgard Self Storage S.A. was founded in 1995 and is based in Luxembourg, Luxembourg.

Earnings Per Share

As for profitability, SHURGARD has a trailing twelve months EPS of €3.25.

PE Ratio

SHURGARD has a trailing twelve months price to earnings ratio of 13.52. Meaning, the purchaser of the share is investing €13.52 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.09%.

Sales Growth

SHURGARD's sales growth is 4.2% for the present quarter and 2.4% for the next.

Yearly Top and Bottom Value

SHURGARD's stock is valued at €43.95 at 11:30 EST, way under its 52-week high of €59.40 and way higher than its 52-week low of €36.70.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Sep 27, 2022, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 2.59%.

More news about SHURGARD.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com